Advertisement
Organisation › Details
Orexo AB (OMX Nordic List, Mid Cap: ORX)
Orexo is a pharmaceutical company focusing on developing treatments for pain and inflammation. The company has four commercialized products, several projects developed in partnership as well as three proprietary development programs. Orexo's registered products are Abstral® for the treatment of break through cancer pain, sold by Kyowa Hakko Kirin/ProStrakan Group plc. in Europe and in the USA, the sleeping pill Edluar™, sold by Meda in the USA, as well as two products for the diagnosis of Helicobacter pylori which are being marketed by the subsidiary Kibion. *
Start | 1995-01-01 established_pre | |
Group | Orexo (Group) | |
Predecessor | Diabact AB | |
Industry | drug delivery technology (drug formulation technology) | |
Industry 2 | diagnostics (medical/biological) | |
Person | Sørensen, Nikolaj (Orexo 201810 CEO joined 201110 as CCO before Pfizer AB + Boston Consulting Group) | |
Person 2 | Juuel, Henrik (Bavarian Nordic 201811– before Orexo + Virgin Mobile + GN ReSound + NNE Pharmaplan + Novo Nordisk) | |
Region | Uppsala | |
Country | Sweden | |
Street | 32A Virdings allé | |
City | 751 05 Uppsala | |
Tel | +46-18-780-8800 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | SEK | |
Annual sales | 783,100,000 (revenues, net, consolidated (2018) 2018-12-31) | |
Profit | 137,900,000 (2018-12-31) | |
Cash | 589,800,000 (2018-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Orexo (Group)
- [1] Bavarian Nordic A/S. (11/1/18). "Press Release: Henrik Juuel Joins Bavarian Nordic as Chief Financial Officer". Copenhagen....
- [2] Orexo AB. (10/24/18). "Press Release: Orexo Appoints Joseph DeFeo as New CFO". Uppsala....
- [3] Bavarian Nordic A/S. (5/31/18). "Press Release: Bavarian Nordic Announces Appointment of Henrik Juuel as Chief Financial Officer". Copenhagen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top